{
    "data": [
        {
            "id": "4402645",
            "title": "Fox Non-GAAP EPS of $0.96 beats by $0.34, revenue of $5.08B beats by $260M",
            "description": "<html><body><ul> <li>Fox <a href=\"https://seekingalpha.com/pr/19990437-fox-reports-second-quarter-fiscal-2025-revenues-of-5_08-billion-net-income-of-388-million-and\">press release</a> (<span class=\"ticker-hover-wrapper\">NASDAQ:<a href=\"https://seekingalpha.com/symbol/FOX\" title=\"Fox Corporation\">FOX</a></span>): Q2 Non-GAAP EPS of $0.96 <span class=\"green\"> beats by $0.34</span>.</li> <li>Revenue of $5.08B (+20.1% Y/Y) <span class=\"green\"> beats by $260M</span>.</li> <li>Quarterly Adjusted EBITDA was $781 million, an increase of $431 million or 123% from the amount reported in the prior year quarter.</li> <li class=\"paywall-full-content invisible\">The company has declared a dividend of $0.27 per Class A and Class B share. This dividend is payable on March 26, 2025 with a record date for determining dividend entitlements of March 5, 2025.</li> </ul> </body></html>",
            "image": null,
            "link": "https://seekingalpha.com/news/4402645-fox-non-gaap-eps-of-096-beats-by-034-revenue-of-508b-beats-by-260m",
            "pub_date": "2025-02-04 16:12:27",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4402647",
            "title": "Mesa Laboratories Non-GAAP EPS of $2.72 beats by $1.21, revenue of $62.84M beats by $4.01M",
            "description": "<html><body><ul>\n<li>Mesa Laboratories <a href=\"https://seekingalpha.com/pr/19990461-mesa-labs-announces-third-quarter-results\">press release</a>  (<span class=\"ticker-hover-wrapper\">NASDAQ:<a href=\"https://seekingalpha.com/symbol/MLAB\" title=\"Mesa Laboratories, Inc.\">MLAB</a></span>): Q3  Non-GAAP EPS of $2.72 <font color=\"green\"> beats by $1.21</font>.</li>\n<li>Revenue of $62.84M (+17.5% Y/Y) <font color=\"green\"> beats by $4.01M</font>.</li>\n<li>\n<em>Non-GAAP core organic revenues</em><sup>1 </sup><em>increase was 13.2%.</em>\n</li>\n<li>\n<em>Non-GAAP adjusted operating income excluding unusual items</em><sup>2</sup><em> increased 13.3% and was 23.5% as a percentage of revenues.</em>\n</li>\n<li>Total Net Leverage Ratios* as of March 31, 2024, June 30, 2024 and September 30, 2024 were 3.84x, 3.78x, and 3.59x, respectively.</li>\n</ul>\n</body></html>",
            "image": null,
            "link": "https://seekingalpha.com/news/4402647-mesa-laboratories-non-gaap-eps-of-272-beats-by-121-revenue-of-6284m-beats-by-401m",
            "pub_date": "2025-02-04 16:15:38",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4402636",
            "title": "Intuitive Machines to redeem outstanding warrants",
            "description": "<html><body><ul> <li dir=\"ltr\">Intuitive Machines (<span class=\"ticker-hover-wrapper\">NASDAQ:<a href=\"https://seekingalpha.com/symbol/LUNR\" title=\"Intuitive Machines, Inc.\">LUNR</a></span>) <a href=\"https://seekingalpha.com/pr/19990288-intuitive-machines-announces-redemption-of-outstanding-warrants\" rel=\"noopener\" target=\"_blank\" title=\"said\">said</a> on Tuesday that it has delivered a notice of redemption to redeem all of its outstanding warrants to purchase shares of the company’s Class A common stock, $0.0001 par value per share, that were issued under<span class=\"paywall-full-content invisible\"> the Warrant Agreement, dated as of September 21, 2021, for a redemption price of $0.01 per warrant. </span> </li> <li class=\"paywall-full-content invisible\" dir=\"ltr\">Under the terms of the Warrant Agreement, the company has the right to redeem all the outstanding warrants if the last sales price of the Class A Common Stock is at least $18 per share for any 20 trading days within any 30-day trading period ending on the third business day before the date on which a notice of redemption is given. </li> <li class=\"paywall-full-content invisible\" dir=\"ltr\">The last sales price of the Class A Common Stock has been at least $18 per share on each of 20 trading days within the 30-day trading period ending on January 30, 2025. </li> <li class=\"paywall-full-content invisible\" dir=\"ltr\">Intuitive Machines (<span class=\"ticker-hover-wrapper\">NASDAQ:<a href=\"https://seekingalpha.com/symbol/LUNR\" title=\"Intuitive Machines, Inc.\">LUNR</a></span>) shares were <span style=\"color: #008000;\">up 2.49%</span> in pre-market trading. </li> </ul> </body></html>",
            "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1368368019/image_1368368019.jpg",
            "link": "https://seekingalpha.com/news/4402636-intuitive-machines-to-redeem-outstanding-warrants",
            "pub_date": "2025-02-04 16:08:31",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4402641",
            "title": "DIH expands strategic partnership with Zahrawi Group",
            "description": "<html><body><ul> <li>DIH Holding (<span class=\"ticker-hover-wrapper\">NASDAQ:<a href=\"https://seekingalpha.com/symbol/DHAI\" title=\"DIH Holding US, Inc.\">DHAI</a></span>) has announced the expansion of their <a href=\"https://seekingalpha.com/pr/19990290-dih-expands-strategic-partnership-with-zahrawi-group\">strategic partnership</a> with Zahrawi Group, DIH's representative and sales partner, to include Saudi Arabia.</li> <li>The expansion aims to enhance the distribution and accessibility of DIH's innovative rehabilitation solutions across these regions, leveraging<span class=\"paywall-full-content invisible\"> Zahrawi Group's established presence and expertise in the healthcare sector. </span> </li> <li class=\"paywall-full-content invisible\">The collaboration will focus on delivering state-of-the-art technologies to improve patient outcomes and support healthcare professionals with cutting-edge tools.</li> <li class=\"paywall-full-content invisible\">By combining DIH's technological expertise with Zahrawi Group's (MTC Company) regional experience, the collaboration is poised to make a meaningful impact on rehabilitation services delivery in the Middle East.</li> <li class=\"paywall-full-content invisible\">\"Extending our partnership with DIH aligns with our mission to provide smart solutions, innovative products, and outstanding services to improve people's lives every day,\" said Abdulrahman Ramadan, Group CEO of Zahrawi Group.</li> </ul> </body></html>",
            "image": null,
            "link": "https://seekingalpha.com/news/4402641-dih-expands-strategic-partnership-with-zahrawi-group",
            "pub_date": "2025-02-04 16:08:55",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4402638",
            "title": "CTS Corporation misses top-line and bottom-line estimates; initiates FY25 outlook",
            "description": "<html><body><ul> <li>CTS Corporation <a href=\"https://seekingalpha.com/pr/19990447-cts-announces-fourth-quarter-and-full-year-2024-results\">press release</a> (<span class=\"ticker-hover-wrapper\">NYSE:<a href=\"https://seekingalpha.com/symbol/CTS\" title=\"CTS Corporation\">CTS</a></span>): Q4 Non-GAAP EPS of $0.53 <span class=\"red\"> misses by $0.01</span>.</li> <li>Revenue of $127M (+1.6% Y/Y) <span class=\"red\"> misses by $5.8M</span>.</li> <li>Adjusted EBITDA margin was 24%, compared to 22% in the fourth quarter of 2023.</li> <li>Operating cash flow was $26 million, down<span class=\"paywall-full-content invisible\"> from $32 million in the fourth quarter of 2023.</span> </li> <li class=\"paywall-full-content invisible\"><p><strong>2025 Guidance:</strong> CTS expects full-year 2025 sales to be in the range of $520-$550 million <strong>vs. $551.56M consensus </strong>and adjusted diluted EPS to be in the range of $2.20-$2.35 <strong>vs. $2.37 consensus</strong>.</p></li> </ul> </body></html>",
            "image": null,
            "link": "https://seekingalpha.com/news/4402638-cts-corporation-misses-top-line-and-bottom-line-estimates-initiates-fy25-outlook",
            "pub_date": "2025-02-04 16:02:58",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4402633",
            "title": "Olin downgraded at RBC Capital Markets on shaky demand recovery",
            "description": "<html><body><p class=\"MsoNormal\">Olin (<span class=\"ticker-hover-wrapper\">NYSE:<a href=\"https://seekingalpha.com/symbol/OLN\" title=\"Olin Corporation\">OLN</a></span>) on Tuesday was downgraded to Sector Perform from a previous investment rating of Outperform by analysts at financial-services firm RBC Capital Markets. They said the chemical maker is facing a “delayed demand recovery,” though anti-dumping laws may help its epoxy-making<span class=\"paywall-full-content invisible\"> unit.</span></p> <p class=\"MsoNormal paywall-full-content invisible\">“While we believe Olin (<span class=\"ticker-hover-wrapper\">NYSE:<a href=\"https://seekingalpha.com/symbol/OLN\" title=\"Olin Corporation\">OLN</a></span>) has best-in-class chlor-alkali assets and strong operational leverage, near-term headwinds remain” to earnings, Arun Viswanathan, analyst at RBC, said in a February 4 report. “Anti-dumping is likely to be a benefit to Epoxy, although Chlor-alkali earnings are likely to see headwinds from tariff implementation and the potential for retaliation.”</p> <p class=\"MsoNormal paywall-full-content invisible\">RBC cut its price target to $30 a share from $45 a share previously, based on an estimated enterprise value that’s an unchanged 7 times earnings before interest, taxes, depreciation and amortization for 2025.</p> <p class=\"MsoNormal paywall-full-content invisible\"> </p> </body></html>",
            "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1411879727/image_1411879727.jpg",
            "link": "https://seekingalpha.com/news/4402633-olin-downgraded-at-rbc-capital-markets-on-shaky-demand-recovery",
            "pub_date": "2025-02-04 15:57:40",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4402618",
            "title": "Petrobras production declined in 2024 but met company target",
            "description": "<html><body><p>Petrobras (NYSE:<a href=\"https://seekingalpha.com/symbol/PBR\">PBR</a>) reported late Monday its Q4 total oil and gas production <a href=\"https://valorinternational.globo.com/business/news/2025/02/04/petrobras-meets-target-but-production-declines-in-2024.ghtml\" rel=\"nofollow\" target=\"_blank\">declined</a> 10.5% to 2.63M boe/day from the year-earlier quarter, while also posting lower sales and exports, which it attributed to a higher number of maintenance shutdowns in theu field.</p> <p class=\"paywall-full-content invisible\">Q4 sales of oil, gas and derivatives fell 8% Y/Y to 2.83M bbl/day, and exports tumbled nearly 22% to 692K bbl/day, as the company's production of oil and natural gas liquids in Brazil fell 11.5% in the period to 2.09M bbl/day while natural gas output dropped 6.1% to 507K boe/day.</p> <p class=\"paywall-full-content invisible\">Petrobras (<span class=\"ticker-hover-wrapper\">NYSE:<a href=\"https://seekingalpha.com/symbol/PBR\" title=\"Petróleo Brasileiro S.A. - Petrobras\">PBR</a></span>) said ~30% of its oil exports went to China in the quarter, compared to 44% in the same period in 2023, while Europe received 38% of its total oil exports, up from 28% a year earlier.</p> <p class=\"paywall-full-content invisible\">For the full year, Petrobras (<a href=\"https://seekingalpha.com/symbol/PBR\" title=\"Petróleo Brasileiro S.A. - Petrobras\">PBR</a>) said it achieved its oil and gas production targets, but annual output of oil, NGLs and natural gas fell 3.1% Y/Y to 2.66M boe/day.</p> <p class=\"paywall-full-content invisible\">Petrobras (<a href=\"https://seekingalpha.com/symbol/PBR\" title=\"Petróleo Brasileiro S.A. - Petrobras\">PBR</a>) said previously that its 2024 production would total ~2.7M boe/day, 3% lower than in 2023 but within the goals outlined in its strategic plan.</p> <p class=\"paywall-full-content invisible\">FY 2024 domestic production of oil and NGL dropped 3.5% compared to 2023 to 2.15M bbl/day, and natural gas output in Brazil slipped less than 1% Y/Y to. 512K boe/day.</p> <p class=\"paywall-full-content invisible\">Petrobras (<a href=\"https://seekingalpha.com/symbol/PBR\" title=\"Petróleo Brasileiro S.A. - Petrobras\">PBR</a>) said it set new annual production records in Brazil’s pre-salt region, with company-operated output of 2.2M boe/day and total operated production of 3.2M boe/day; the pre-salt accounted for 81% of the company’s total production in 2024.</p> </body></html>",
            "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1332149589/image_1332149589.jpg",
            "link": "https://seekingalpha.com/news/4402618-petrobras-production-declines-in-2024-but-meets-company-target",
            "pub_date": "2025-02-04 15:59:16",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4402631",
            "title": "Ametek acquires Kern Microtechnik, terms undisclosed",
            "description": "<html><body><ul> <li>AMETEK (<span class=\"ticker-hover-wrapper\">NYSE:<a href=\"https://seekingalpha.com/symbol/AME\" title=\"AMETEK, Inc.\">AME</a></span>) has announced the acquisition of Kern Microtechnik, a manufacturer of high-precision machining and optical inspection solutions.</li> <li>Kern specializes in the design and manufacture of ultra-precision manufacturing solutions capable of achieving sub-micron level accuracy.</li> <li>Kern's advanced product portfolio includes high-precision<span class=\"paywall-full-content invisible\"> machining solutions and optical tool inspection systems.</span> </li> <li class=\"paywall-full-content invisible\">Kern is headquartered near Munich, Germany and has annual <a href=\"https://seekingalpha.com/pr/19990113-ametek-acquires-kern-microtechnik\">sales of ~€50M</a>. Kern will join AMETEK as part of its Electronic Instruments Group.</li> <li class=\"paywall-full-content invisible\">Their highly engineered solutions support a wide range of applications that demand exceptional precision, including within the medical, semiconductor, research, and space markets.</li> </ul> </body></html>",
            "image": null,
            "link": "https://seekingalpha.com/news/4402631-ametek-acquires-kern-microtechnik-terms-undisclosed",
            "pub_date": "2025-02-04 15:55:18",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4402625",
            "title": "CME Group reports 2% Y/Y rise in January volume, record Cryptocurrency ADV",
            "description": "<html><body><ul> <li>Derivatives marketplace CME Group (<span class=\"ticker-hover-wrapper\">NASDAQ:<a href=\"https://seekingalpha.com/symbol/CME\" title=\"CME Group Inc.\">CME</a></span>) <a href=\"https://seekingalpha.com/pr/19990263-cme-group-reports-record-january-adv-of-25_7-million-contracts\" rel=\"noopener\" target=\"_blank\" title=\"announced\">announced</a> on Tuesday that its January average daily volume reached 25.7M contracts (+2% Y/Y), the highest ADV on record.</li> <li>The company reported a record January Cryptocurrency ADV of 198K ($13.6B notional).</li> <li>CME shares were trading <span class=\"paywall-full-content invisible\" style=\"color: #008000;\">+0.15%</span><span class=\"paywall-full-content invisible\"> pre-market at $241.00.</span> </li> <li class=\"paywall-full-content invisible\"><span style=\"color: #000000;\">The monthly Interest Rate ADV came in at 11.7M contracts, while Equity Index ADV stood at 7M contracts.</span></li> <li class=\"paywall-full-content invisible\"><span style=\"color: #000000;\">Energy ADV was 3.2M contracts, Agricultural ADV was 2M contracts, Foreign Exchange ADV was 1M contracts, and Metals ADV was 697K contracts.</span></li> </ul> </body></html>",
            "image": null,
            "link": "https://seekingalpha.com/news/4402625-cme-group-reports-2-yy-rise-in-january-volume-record-cryptocurrency-adv",
            "pub_date": "2025-02-04 15:55:31",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4402626",
            "title": "Tonix Pharmaceuticals promotes Fogarty to CTO",
            "description": "<html><body><ul> <li>Tonix Pharmaceuticals Holding (<span class=\"ticker-hover-wrapper\">NASDAQ:<a href=\"https://seekingalpha.com/symbol/TNXP\" title=\"Tonix Pharmaceuticals Holding Corp.\">TNXP</a></span>) has announced the promotion of Siobhan Fogarty to <a href=\"https://seekingalpha.com/pr/19990139-tonix-pharmaceuticals-promotes-siobhan-fogarty-to-chief-technical-officer\">Chief Technical Officer</a>, effective immediately.</li> <li>Ms. Fogarty joined Tonix in 2016 and previously served as Executive Vice President of Product Development.</li> <li>In December, Tonix announced that the U.S. FDA assigned<span class=\"paywall-full-content invisible\"> a Prescription Drug User Fee Act goal date of August 15, 2025, for a decision on marketing authorization for TNX-102 SL (cyclobenzaprine HCl sublingual tablets) 5.6 mg for the management of fibromyalgia. </span> </li> <li class=\"paywall-full-content invisible\">TNX-102 SL is a non-opioid, centrally-acting analgesic. Fibromyalgia is a common chronic pain condition that affects mostly women.</li> <li class=\"paywall-full-content invisible\">TNXP <span class=\"red\">-17.9%</span> premarket to $0.16.</li> </ul> </body></html>",
            "image": null,
            "link": "https://seekingalpha.com/news/4402626-tonix-pharmaceuticals-promotes-fogarty-to-cto",
            "pub_date": "2025-02-04 15:46:57",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        }
    ]
}